{"id":58317,"date":"2026-06-04T21:59:36","date_gmt":"2026-06-04T12:59:36","guid":{"rendered":"https:\/\/japanir.jp\/en\/company\/company-4574\/"},"modified":"2026-08-23T12:53:21","modified_gmt":"2026-08-23T03:53:21","slug":"company-4574","status":"publish","type":"company","link":"https:\/\/japanir.jp\/en\/company\/company-4574\/","title":{"rendered":"TAIKO PHARMACEUTICAL CO LTD"},"content":{"rendered":"","protected":false},"featured_media":0,"template":"","meta":{"Ticker":"4574","DATE":"2026-01-09","longName":"Taiko Pharmaceutical Co.,Ltd.","company_name_ja":"","fullTimeEmployees":220,"address":"","phone":"","website":"https:\/\/www.seirogan.co.jp","industry":"Drug Manufacturers - Specialty & Generic","sector":"Healthcare","regularMarketPrice":305,"financialCurrency":"","marketCap":15309,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":18.379999999999999,"epsForward":0,"bookValue":0,"totalRevenue":6397000000,"OperatingIncome":459000000,"operatingMargins":7.1799999999999997,"NetIncome":923000000,"profitMargins":14.43,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":10.84,"recommendationMean":0,"recommendationKey":"none","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"{\"success\": true, \"fetched_at\": \"2026-08-01T04:09:28.288913\", \"ticker\": \"4574\", \"ticker_full\": \"4574.T\", \"company_name\": \"TAIKO PHARMACEUTICAL CO LTD\", \"analyst_recommendations\": {\"has_data\": true, \"period\": \"0\", \"strong_buy\": 0, \"buy\": 0, \"hold\": 0, \"sell\": 0, \"strong_sell\": 0, \"total_analysts\": 0, \"recommendation_key\": \"none\", \"recommendation_mean\": null}, \"target_prices\": {\"has_data\": true, \"current\": 253.0, \"high\": null, \"low\": null, \"mean\": null, \"median\": null}, \"earnings_dates\": {\"has_data\": false}, \"shareholders\": {\"has_data\": true, \"insider_pct\": 36.86, \"institution_pct\": 5.59, \"major_holders\": [{\"label\": \"\", \"value\": 36.86}, {\"label\": \"\", \"value\": 5.59}, {\"label\": \"\", \"value\": 8.86}, {\"label\": \"\", \"value\": 15.0}], \"institutional_holders\": [], \"mutualfund_holders\": []}}","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"Taiko Pharmaceutical Co.,Ltd. manufactures and sells over-the-counter (OTC) medicines and quasi drugs in Japan and internationally. The company provides OTC medicines under the SEIROGAN, SEIROGAN TOI A and SEIROGAN Quick C, PISHUT OD Tablet brand names; and quasi-drugs under the RAPPA INTESTINAL REGULATOR BF brand names. It offers sanitation control products under the Cleverin PR, Cleverin Pro Stick, and Cleverin Pro name. In addition, the company manufactures and sells wood vinegar-based products. It exports its products. The company was incorporated in 1946 and is headquartered in Osaka, Japan.","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":3.2999999999999998,"get_dividend_history_year2":35,"get_dividend_history_year3":11.67,"get_dividend_history_year4":11.67,"get_dividend_history_year5":6.6699999999999999,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"financial_data":"","detailed_financial_data":"{\"success\": true, \"fetched_at\": \"2026-08-23T02:16:34.535379\", \"ticker\": \"4574\", \"ticker_full\": \"4574.T\", \"company_name\": \"TAIKO PHARMACEUTICAL CO LTD\", \"company_info\": {\"name_en\": \"TAIKO PHARMACEUTICAL CO LTD\", \"long_name\": \"Taiko Pharmaceutical Co.,Ltd.\", \"sector\": \"Healthcare\", \"industry\": \"Drug Manufacturers - Specialty & Generic\", \"website\": \"https:\/\/www.seirogan.co.jp\", \"employees\": 220, \"country\": \"Japan\", \"city\": \"Osaka\", \"address\": \"1-4-1, Nishi-Honmachi\", \"description\": \"Taiko Pharmaceutical Co.,Ltd. manufactures and sells over-the-counter (OTC) medicines and quasi drugs in Japan and internationally. The company provides OTC medicines under the SEIROGAN, SEIROGAN TOI A and SEIROGAN Quick C, PISHUT OD Tablet brand names; and quasi-drugs under the RAPPA INTESTINAL REGULATOR BF brand names. It offers sanitation control products under the Cleverin PR, Cleverin Pro Stick, and Cleverin Pro name. In addition, the company manufactures and sells wood vinegar-based products. It exports its products. The company was incorporated in 1946 and is headquartered in Osaka, Japan.\"}, \"price_trend\": {\"ma_5\": {\"ma_value\": 268.0, \"deviation\": 0.0, \"trend\": \"down\"}, \"ma_25\": {\"ma_value\": 260.12, \"deviation\": 3.03, \"trend\": \"up\"}, \"ma_75\": {\"ma_value\": 265.04, \"deviation\": 1.12, \"trend\": \"up\"}, \"ma_200\": {\"ma_value\": 282.5, \"deviation\": -5.13, \"trend\": \"down\"}}, \"financials\": {\"years\": [{\"year\": 2025, \"revenue\": 6397000000.0, \"revenue_fmt\": \"\u00a564\u5104\", \"gross_profit\": 3481000000.0, \"gross_profit_fmt\": \"\u00a535\u5104\", \"operating_income\": 459000000.0, \"operating_income_fmt\": \"\u00a55\u5104\", \"ebit\": 963000000.0, \"ebit_fmt\": \"\u00a510\u5104\", \"net_income\": 923000000.0, \"net_income_fmt\": \"\u00a59\u5104\", \"eps\": 18.38, \"operating_margin\": 7.18, \"total_assets\": 12270000000.0, \"total_assets_fmt\": \"\u00a5123\u5104\", \"total_equity\": 8518000000.0, \"total_equity_fmt\": \"\u00a585\u5104\", \"total_debt\": 970000000.0, \"total_debt_fmt\": \"\u00a510\u5104\", \"total_cash\": 4256000000.0, \"total_cash_fmt\": \"\u00a543\u5104\", \"equity_ratio\": 69.42, \"de_ratio\": 0.11, \"current_ratio\": 3.36, \"operating_cf\": 814000000.0, \"operating_cf_fmt\": \"\u00a58\u5104\", \"investing_cf\": 142000000.0, \"investing_cf_fmt\": \"\u00a51\u5104\", \"financing_cf\": -1227000000.0, \"financing_cf_fmt\": \"-\u00a512\u5104\", \"free_cf\": 510000000.0, \"free_cf_fmt\": \"\u00a55\u5104\", \"net_margin\": 14.43, \"roe\": 10.84, \"roa\": 7.52}, {\"year\": 2024, \"revenue\": 6292000000.0, \"revenue_fmt\": \"\u00a563\u5104\", \"gross_profit\": 3666000000.0, \"gross_profit_fmt\": \"\u00a537\u5104\", \"operating_income\": 630000000.0, \"operating_income_fmt\": \"\u00a56\u5104\", \"ebit\": 573000000.0, \"ebit_fmt\": \"\u00a56\u5104\", \"net_income\": 898000000.0, \"net_income_fmt\": \"\u00a59\u5104\", \"eps\": 17.9, \"operating_margin\": 10.01, \"total_assets\": 12914000000.0, \"total_assets_fmt\": \"\u00a5129\u5104\", \"total_equity\": 7963000000.0, \"total_equity_fmt\": \"\u00a580\u5104\", \"total_debt\": 2211000000.0, \"total_debt_fmt\": \"\u00a522\u5104\", \"total_cash\": 4532000000.0, \"total_cash_fmt\": \"\u00a545\u5104\", \"equity_ratio\": 61.66, \"de_ratio\": 0.28, \"current_ratio\": 3.07, \"operating_cf\": 362000000.0, \"operating_cf_fmt\": \"\u00a54\u5104\", \"investing_cf\": -5000000.0, \"investing_cf_fmt\": \"-\u00a55.0M\", \"financing_cf\": -1181000000.0, \"financing_cf_fmt\": \"-\u00a512\u5104\", \"free_cf\": 175000000.0, \"free_cf_fmt\": \"\u00a52\u5104\", \"net_margin\": 14.27, \"roe\": 11.28, \"roa\": 6.95}, {\"year\": 2023, \"revenue\": 6120000000.0, \"revenue_fmt\": \"\u00a561\u5104\", \"gross_profit\": 2577000000.0, \"gross_profit_fmt\": \"\u00a526\u5104\", \"operating_income\": -1006000000.0, \"operating_income_fmt\": \"-\u00a510\u5104\", \"ebit\": -3555000000.0, \"ebit_fmt\": \"-\u00a536\u5104\", \"net_income\": -3611000000.0, \"net_income_fmt\": \"-\u00a536\u5104\", \"eps\": -76.25, \"operating_margin\": -16.44, \"total_assets\": 13220000000.0, \"total_assets_fmt\": \"\u00a5132\u5104\", \"total_equity\": 6738000000.0, \"total_equity_fmt\": \"\u00a567\u5104\", \"total_debt\": 3254000000.0, \"total_debt_fmt\": \"\u00a533\u5104\", \"total_cash\": 5484000000.0, \"total_cash_fmt\": \"\u00a555\u5104\", \"equity_ratio\": 50.97, \"de_ratio\": 0.48, \"current_ratio\": 2.99, \"operating_cf\": -307000000.0, \"operating_cf_fmt\": \"-\u00a53\u5104\", \"investing_cf\": 1166000000.0, \"investing_cf_fmt\": \"\u00a512\u5104\", \"financing_cf\": 1539000000.0, \"financing_cf_fmt\": \"\u00a515\u5104\", \"free_cf\": -421000000.0, \"free_cf_fmt\": \"-\u00a54\u5104\", \"net_margin\": -59.0, \"roe\": -53.59, \"roa\": -27.31}, {\"year\": 2022, \"revenue\": 5040000000.0, \"revenue_fmt\": \"\u00a550\u5104\", \"gross_profit\": 1078000000.0, \"gross_profit_fmt\": \"\u00a511\u5104\", \"operating_income\": -3079000000.0, \"operating_income_fmt\": \"-\u00a531\u5104\", \"ebit\": -4859000000.0, \"ebit_fmt\": \"-\u00a549\u5104\", \"net_income\": -4895000000.0, \"net_income_fmt\": \"-\u00a549\u5104\", \"eps\": -112.26, \"operating_margin\": -61.09, \"total_assets\": 15046000000.0, \"total_assets_fmt\": \"\u00a5150\u5104\", \"total_equity\": 8043000000.0, \"total_equity_fmt\": \"\u00a580\u5104\", \"total_debt\": 3809000000.0, \"total_debt_fmt\": \"\u00a538\u5104\", \"total_cash\": 3105000000.0, \"total_cash_fmt\": \"\u00a531\u5104\", \"equity_ratio\": 53.46, \"de_ratio\": 0.47, \"current_ratio\": 2.71, \"operating_cf\": -1994000000.0, \"operating_cf_fmt\": \"-\u00a520\u5104\", \"investing_cf\": 190000000.0, \"investing_cf_fmt\": \"\u00a52\u5104\", \"financing_cf\": -997000000.0, \"financing_cf_fmt\": \"-\u00a510\u5104\", \"free_cf\": -2078000000.0, \"free_cf_fmt\": \"-\u00a521\u5104\", \"net_margin\": -97.12, \"roe\": -60.86, \"roa\": -32.53}], \"has_data\": true}, \"dividends\": {\"history\": [{\"year\": 2017, \"amount\": 6.67}, {\"year\": 2018, \"amount\": 11.67}, {\"year\": 2019, \"amount\": 11.67}, {\"year\": 2020, \"amount\": 35.0}, {\"year\": 2025, \"amount\": 3.3}], \"latest\": 3.3, \"has_data\": true}}","ma_5_value":0,"ma_5_deviation":0,"ma_5_trend":"","ma_25_value":0,"ma_25_deviation":0,"ma_25_trend":"","ma_75_value":0,"ma_75_deviation":0,"ma_75_trend":"","ma_200_value":0,"ma_200_deviation":0,"ma_200_trend":"","previousClose":0,"open":0,"dayHigh":0,"dayLow":0,"volume":0,"averageVolume":0,"revenueGrowth":0},"sector":[],"class_list":["post-58317","company","type-company","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>TAIKO PHARMACEUTICAL CO LTD - Japan IR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/japanir.jp\/en\/company\/company-4574\/\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4574\/\",\"url\":\"https:\/\/japanir.jp\/en\/company\/company-4574\/\",\"name\":\"TAIKO PHARMACEUTICAL CO LTD - Japan IR\",\"isPartOf\":{\"@id\":\"https:\/\/japanir.jp\/en\/#website\"},\"datePublished\":\"2026-06-04T12:59:36+00:00\",\"dateModified\":\"2026-08-23T03:53:21+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4574\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/japanir.jp\/en\/company\/company-4574\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4574\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/japanir.jp\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"TAIKO PHARMACEUTICAL CO LTD\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/japanir.jp\/en\/#website\",\"url\":\"https:\/\/japanir.jp\/en\/\",\"name\":\"Japan IR\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/japanir.jp\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"TAIKO PHARMACEUTICAL CO LTD - Japan IR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/japanir.jp\/en\/company\/company-4574\/","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/japanir.jp\/en\/company\/company-4574\/","url":"https:\/\/japanir.jp\/en\/company\/company-4574\/","name":"TAIKO PHARMACEUTICAL CO LTD - Japan IR","isPartOf":{"@id":"https:\/\/japanir.jp\/en\/#website"},"datePublished":"2026-06-04T12:59:36+00:00","dateModified":"2026-08-23T03:53:21+00:00","breadcrumb":{"@id":"https:\/\/japanir.jp\/en\/company\/company-4574\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/japanir.jp\/en\/company\/company-4574\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/japanir.jp\/en\/company\/company-4574\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/japanir.jp\/en\/"},{"@type":"ListItem","position":2,"name":"TAIKO PHARMACEUTICAL CO LTD"}]},{"@type":"WebSite","@id":"https:\/\/japanir.jp\/en\/#website","url":"https:\/\/japanir.jp\/en\/","name":"Japan IR","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/japanir.jp\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/company\/58317","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/company"}],"about":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/types\/company"}],"wp:attachment":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/media?parent=58317"}],"wp:term":[{"taxonomy":"sector","embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/sector?post=58317"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}